XTL Biopharmaceutica (Israel) Technical Analysis

XTLB Stock  ILS 9.00  0.10  1.12%   
As of the 19th of April, XTL Biopharmaceutica maintains the Mean Deviation of 8.23, downside deviation of 6.55, and Risk Adjusted Performance of 0.0931. In relation to fundamental indicators, the technical analysis model lets you check available technical drivers of XTL Biopharmaceuticals, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for XTL Biopharmaceuticals, which can be compared to its peers. Please check out XTL Biopharmaceuticals information ratio, treynor ratio, value at risk, as well as the relationship between the jensen alpha and maximum drawdown to decide if XTL Biopharmaceuticals is priced some-what accurately, providing market reflects its latest price of 9.0 per share.

XTL Biopharmaceutica Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as XTL, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to XTL
  
XTL Biopharmaceutica's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of XTL Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of XTL Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

XTL Biopharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of XTL Biopharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

XTL Biopharmaceuticals Trend Analysis

Use this graph to draw trend lines for XTL Biopharmaceuticals. You can use it to identify possible trend reversals for XTL Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual XTL Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

XTL Biopharmaceutica Best Fit Change Line

The following chart estimates an ordinary least squares regression model for XTL Biopharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.14  , which means XTL Biopharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 709.42, which is the sum of squared deviations for the predicted XTL Biopharmaceutica price change compared to its average price change.

About XTL Biopharmaceutica Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of XTL Biopharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on XTL Biopharmaceuticals price pattern first instead of the macroeconomic environment surrounding XTL Biopharmaceuticals. By analyzing XTL Biopharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of XTL Biopharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to XTL Biopharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.

XTL Biopharmaceutica April 19, 2024 Technical Indicators

Most technical analysis of XTL help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for XTL from various momentum indicators to cycle indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for XTL Stock analysis

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.